Drug intelligence / Profile preview

celecoxib + gabapentin

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Celecoxib + gabapentin is a combination of two small molecule drugs used primarily as part of multimodal analgesia for the management of postoperative pain. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, classified as a nonsteroidal anti-inflammatory drug (NSAID), which reduces inflammation and pain by inhibiting prostaglandin synthesis. Gabapentin is an anticonvulsant that modulates voltage-gated calcium channels, reducing excitatory neurotransmitter release and thereby decreasing neuropathic pain signaling. The combination has been shown in multiple clinical trials to provide additive or synergistic effects in reducing postoperative pain and opioid consumption compared to either agent alone, with improved patient satisfaction and fewer side effects than higher doses of gabapentin alone[2][3][5][6]. This regimen is commonly used perioperatively for orthopedic or spine surgeries.

02

Targets

CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on celecoxib + gabapentin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on celecoxib + gabapentin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call